Pluri (PLUR) Competitors

Pluri (NASDAQ:PLUR) and Vaxart (NASDAQ:VXRT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, community ranking, media sentiment, earnings, risk and institutional ownership.

Does the MarketBeat Community favor PLUR or VXRT?

Vaxart received 310 more outperform votes than Pluri when rated by MarketBeat users.

Company	Underperform	Outperform
Pluri	N/A	N/A
Vaxart	Outperform Votes 310 65.54%	Underperform Votes 163 34.46%

Which has more volatility & risk, PLUR or VXRT?

Pluri has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Vaxart has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500.

Do analysts recommend PLUR or VXRT?

Vaxart has a consensus target price of $4.00, suggesting a potential upside of 675.04%. Given Vaxart's stronger consensus rating and higher possible upside, analysts clearly believe Vaxart is more favorable than Pluri.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pluri	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vaxart	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders believe in PLUR or VXRT?

16.6% of Pluri shares are owned by institutional investors. Comparatively, 18.0% of Vaxart shares are owned by institutional investors. 10.2% of Pluri shares are owned by insiders. Comparatively, 2.6% of Vaxart shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the media favor PLUR or VXRT?

In the previous week, Vaxart had 5 more articles in the media than Pluri. MarketBeat recorded 7 mentions for Vaxart and 2 mentions for Pluri. Vaxart's average media sentiment score of 0.32 beat Pluri's score of 0.04 indicating that Vaxart is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pluri	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Vaxart	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Which has higher valuation and earnings, PLUR or VXRT?

Pluri has higher earnings, but lower revenue than Vaxart. Vaxart is trading at a lower price-to-earnings ratio than Pluri, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pluri	$678K	45.41	-$20.89M	-$5.60	-0.79
Vaxart	$20.14M	5.83	-$82.46M	-$0.41	-1.26

Is PLUR or VXRT more profitable?

Vaxart has a net margin of -431.61% compared to Pluri's net margin of -3,551.49%. Vaxart's return on equity of -110.46% beat Pluri's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pluri	-3,551.49%	-2,778.13%	-83.61%
Vaxart	-431.61%	-110.46%	-62.78%

Summary

Vaxart beats Pluri on 12 of the 17 factors compared between the two stocks.